Liaoning Chengda
Establishment time : 1995
website : www.lncd.com
Main Product : Steel products, construction materials
Company Profile
Liaoning Chengda is a leading steel manufacturer in China, specializing in the production of high-quality steel products for various industries. Founded in 1995, the company has grown to become a key player in the domestic market, offering a wide range of construction materials and steel products to meet the needs of its customers. With a medium-sized operation, Liaoning Chengda continues to strive for excellence in quality and customer satisfaction.
Changchun Zhuoyi Biological Co., Ltd
Company Profile
Changchun Zhuoyi Biological Co., Ltd., located in Shuangyang Economic Development Zone of Changchun City, is a key vaccine manufacturer invested by Zhejiang SelCorning Biotechnology Co., Ltd. in Jilin Province, and a vice chairman unit of Zhejiang Chamber of Commerce in Jilin Province. The company was founded on January 27, 2005. Mr. Feng Xingfu, chairman and general manager of the company, graduated from the Department of Biology, University of Science and Technology of China, and has been engaged in the marketing and enterprise management of biological products since the 1980s. The company has a registered capital of one hundred and one million six hundred and ninety-two thousand seven hundred and eighty-four yuan, covers an area of 41600 square meters, and has the leading vaccine research and development and production capacity in China. Changchun Zhuoyi Biological Co., Ltd. is a new vaccine manufacturer integrating R&D, production and sales. At present, the biological products approved by the company are mainly Rabies Vaccine (Vero cell) for Human Use, Freeze-dried. The company successfully passed the two in one inspection at the end of 2016 and obtained the registration approval and GMP certificate, which was officially put into production in January 2017. The company's existing production workshop covers an area of about 5700 square meters, with a cumulative investment of 400 million yuan. At present, the maximum annual output is 1 million people. The second phase workshop has been completed at the end of 2018, and will be officially produced in 2020. By then, the production capacity can reach 4 million people. The company has nearly 2000 square meters of pilot scale research workshop, advanced equipment such as bioreactor, ultrafiltration system, AKTA purification workstation, fluorescence microscope, etc., which are used for virus culture, improvement of purification system and identification of recombinant protein. The company has maintained close scientific research cooperation with many scientific research institutions at home and abroad. At present, the company is developing a serum rabies vaccine and a broad-spectrum human papillomavirus vaccine jointly developed with the Institute of Basic Medicine of the Chinese Academy of Medical Sciences. It is planned to cooperate with Murdoch Children's Research Institute in Australia to develop the round vaccine project. At the same time, the company also actively explores the path of internationalization. At present, the company has started to register in the Philippines, Pakistan, Cambodia, Bangladesh, Mongolia, Uzbekistan and other countries. It is estimated that the export of finished products in some markets will be realized by 2020. The company's technical cooperation project with Australia is one of the company's many international cooperation projects. The company always adheres to the concept of "standardized management, quality first", and adheres to the core values of "honesty, diligence, innovation, preciseness, learning and happiness", so as to provide high-quality vaccine products to serve the health of the people.
Zhejiang Tianyuan Bio-Pharmaceutical
Establishment time : 2000
website : www.tianyuanbio.com
Main Product : heparin sodium, chondroitin sulfate, hyaluronic acid, etc.
Company Profile
Zhejiang Tianyuan Bio-Pharmaceutical is a pharmaceutical company specializing in the production of bio-pharmaceutical products such as heparin sodium, chondroitin sulfate, and hyaluronic acid. With a focus on innovation and quality, the company has established itself as a key player in the global market, serving customers in China, Asia, Europe, and North America. With a large workforce of over 1000 employees, Zhejiang Tianyuan Bio-Pharmaceutical continues to expand its product offerings and market reach.
Changchun Baike
Establishment time : 2006
website : www.changchunbaike.com
Main Product : Automotive parts and components
Company Profile
Changchun Baike is a leading manufacturer of automotive parts and components in China, specializing in high-quality products for various vehicle models. With a focus on innovation and customer satisfaction, the company has established a strong presence in the domestic market.
Wuhan Institute of Biological Products
Establishment time : 1965
website : http://www.whbp.com.cn/
Main Product : Vaccines, biological products
Company Profile
Wuhan Institute of Biological Products is a renowned biopharmaceutical company with a history dating back to 1965. The company specializes in the development and production of vaccines and biological products. With a large company size and a strong presence in both domestic and international markets, Wuhan Institute of Biological Products is a leading player in the industry known for its innovative products and research and development capabilities. Visit their website for more information on their products and services.
Chengdu Institute of Biological Products
Establishment time : 1967
website : http://www.cibp.com.cn/
Main Product : vaccines, biological products
Company Profile
Chengdu Institute of Biological Products is a state-owned enterprise in China specializing in the research, development, and production of vaccines and biological products. With over 50 years of experience, the company has established itself as a trusted provider of healthcare solutions both in China and internationally.
Changchun Institute of Biological Products
Establishment time : 1958
website : http://www.cibp.cdic.com.cn/
Main Product : vaccines, biological products
Company Profile
Changchun Institute of Biological Products is a state-owned enterprise that specializes in the research, development, and production of vaccines and biological products. With over 60 years of experience in the industry, the company has become a trusted name in the healthcare sector, providing essential vaccines to protect public health.
Dalian Hissen Bio-Pharmaceutical
Establishment time : Dalian Hissen Bio-Pharmaceutical was founded in 2006.
website :
Main Product : With a medium-sized workforce, the company operates in both domestic and international markets.
Company Profile
The company continues to expand its presence in the global biopharmaceutical market.
Beijing Tiantan Biological Products
Establishment time : Beijing Tiantan Biological Products Co., Ltd. was established in 1992.
website :
Main Product : With a medium-sized operation, Beijing Tiantan Biological Products has a strong presence in the domestic market.
Company Profile
For more information, visit the company's website at www.btbp.com.cn.
Shanghai Institute of Biological Products
Establishment time : Shanghai Institute of Biological Products (SIBP) was established in 1969.
website :
Main Product : With a large company size, SIBP is a key player in the industry.
Company Profile
For more information, visit SIBP's website at http://www.sibp.com.cn/.
May 22, 2024
